38. Medical and Pharmaceutical Innovation (and Policy)
| Date | Source | Title | Summary | Other Categories |
| 07.26.2001 | Nature | Drugs approval process gets speed treatment | A proposal adopted by the European Commission (EC) on 18 July would cut the average licensing time for new active substances from 18 months to about 9 months. The plan will now go to the Council of Ministers, which represents the 15 members of the EU, and to the European Parliament. | |
| 04.12.2001 | BBC News | Organs for operations deal | The New England Medical Center, in Boston, is encouraging people to donate their kidneys to strangers by promising early operations for their relatives as a reward. The hospital is though to be the first to offer this sort of incentive to cut waiting lists. | 4. Ethical and Social Concerns Arising out of Biotechnology, 30. Xenotransplantation |
| 03.08.2001 | BBC News | Superbug genetic trigger identified |
US scientists have pinpointed how superbugs become resistant to antibiotics. They identified how bacteria switch on the genetic machinery that enables bugs to evolve resistance to antibiotics like penicillin. The discovery raises the possibility of developing pharmaceuticals that will be more effective against infections caused by staphylococci bacteria. |
|
| 03.07.2001 | BBC News | New anti-ageing insight | Scientists at the Massachusetts Institute of Technology (MIT) have extended the lifespan of worms in a move that could yield clues to human ageing. The tiny roundworms survived up to 50% longer when given an "anti-ageing" gene from yeast. The work could yield genetic clues to human ageing and speed the search for anti-ageing drugs. | |
| 12.19.2000 | Washington Post (Washtech.com) | Healing the online patient | Telemedicine appears to have a promising future as an economically sound and medically beneficial alternative to traditional visits to the doctor. |